Impact of Tobacco Use on Herpes Simplex Virus Infections: Findings from
a National Survey
Abstract
Background: Herpes Simplex Virus (HSV) infections, primarily
caused by HSV-1 and HSV-2, are prevalent worldwide and carry significant
health implications. The impact of tobacco use on HSV infections,
however, remains underexplored. Methods: This cross-sectional
study utilized the National Health and Nutrition Examination Survey
(NHANES) database (2009-2016) to investigate the link between Tobacco
use and HSV infections among U.S. adults. Smoking status, volume, and
serum cotinine levels were analyzed, alongside demographic and
behavioral factors. Propensity score matching (PSM) was employed to
adjust for confounders such as sexual behavior. Results: Our
study involved 5,693 participants to explore the relationship of tobacco
use and HSV infection. We found that smokers, particularly current
smokers, have a significantly increased risk of both HSV-1 and HSV-2
infections compared to non-smokers. Specifically, the adjusted odds
ratio (OR) for HSV-1 in current smokers was 1.36 (95% CI: 1.16-1.59,
p<0.001), and for HSV-2, it was 2.37 (95% CI: 1.88-3,
p<0.001). The risk escalates with the intensity of
smoking. Elevated serum cotinine levels correlated with an increased
risk of HSV infection[HSV-1:1.13 (95% CI:1.09~1.18,
p<0.001); HSV-2:1.33 (95% CI:1.25~1.41,
p<0.001)]. After propensity score matching (PSM) for
factors such as age, gender, sexual behavior, and condom use, these
associations remained significant. Conclusion: Tobacco use is
significantly associated with an increased risk of HSV infections,
highlighting the importance of reducing tobacco exposure in public
health strategies against HSV. Further longitudinal studies are
warranted to establish causality and explore underlying mechanisms.